Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  HIV Infection

  Free Subscription


Articles published in J Infect Dis

Retrieve available abstracts of 182 articles:
HTML format
Text format



Single Articles


    October 2018
  1. RODRIGUEZ-GALLEGO E, Tarancon-Diez L, Garcia F, Del Romero J, et al
    Proteomic Profile Associated with Loss of Spontaneous HIV-1 Elite Control.
    J Infect Dis. 2018 Oct 12. pii: 5127217. doi: 10.1093.
    PubMed     Text format     Abstract available


  2. SUTHAR AB, Coggin W, Raizes E
    Antimicrobial Resistance and Substandard and Falsified Medicines: The Case of HIV/AIDS.
    J Infect Dis. 2018 Oct 11. pii: 5126519. doi: 10.1093.
    PubMed     Text format    


  3. WALLIS CL, Godfrey C, Fitzgibbon JE, Mellors JW, et al
    Reply to Suthar et al.
    J Infect Dis. 2018 Oct 11. pii: 5126520. doi: 10.1093.
    PubMed     Text format    


  4. XIA Q, Coeytaux K, Braunstein SL, Torian LV, et al
    Proposing a New Indicator for the National Human Immunodeficiency Virus/AIDS Strategy: Percentage of Newly Diagnosed Persons Achieving Viral Suppression Within 3 Months of Diagnosis.
    J Infect Dis. 2018 Oct 10. pii: 5116324. doi: 10.1093.
    PubMed     Text format     Abstract available


  5. DOMBROWSKI JC, Baeten JM
    It's Time to Make the Time to Viral Suppression After HIV Diagnosis a Metric of HIV Care Success.
    J Infect Dis. 2018 Oct 10. pii: 5116321. doi: 10.1093.
    PubMed     Text format    


  6. SZANIAWSKI MA, Spivak AM, Bosque A, Planelles V, et al
    Sex influences SAMHD1 activity and susceptibility to HIV-1 in primary human macrophages.
    J Infect Dis. 2018 Oct 8. pii: 5123692. doi: 10.1093.
    PubMed     Text format     Abstract available


  7. RICHARDS V
    Should we consider marijuana use in relation to physical activity and cognitive impairment in persons with HIV infection?
    J Infect Dis. 2018 Oct 5. pii: 5115716. doi: 10.1093.
    PubMed     Text format    


  8. JAIMES-BERNAL C, Rallon N, Benito JM, Mohamed-Balghata MO, et al
    Knock-out IFNL4 gene variant is associated with protection from sexually transmitted HIV-1 infection.
    J Infect Dis. 2018 Oct 5. pii: 5115710. doi: 10.1093.
    PubMed     Text format     Abstract available


    September 2018
  9. MARRA E, Lin C, Clifford GM
    Type-specific anal human papillomavirus prevalence among men, according to sexual preference and HIV status: a systematic literature review and meta-analysis.
    J Infect Dis. 2018 Sep 20. pii: 5103515. doi: 10.1093.
    PubMed     Text format     Abstract available


  10. GUPTA SK, Liu Z, Sims EC, Repass MJ, et al
    Endothelial Colony Forming Cell Function Is Reduced in HIV.
    J Infect Dis. 2018 Sep 18. pii: 5099934. doi: 10.1093.
    PubMed     Text format     Abstract available


  11. KEHRMANN J, Menzel J, Saeedghalati M, Obeid R, et al
    Gut microbiota in HIV-infected individuals linked to coronary heart disease.
    J Infect Dis. 2018 Sep 7. pii: 5092661. doi: 10.1093.
    PubMed     Text format     Abstract available


    August 2018
  12. SCHWETZ TA, Fauci AS
    The Extended Impact of Human Immunodeficiency Virus/AIDS Research.
    J Infect Dis. 2018 Aug 28. pii: 5063659. doi: 10.1093.
    PubMed     Text format     Abstract available


  13. LEDDY AM, Roque A, Sheira LA, Frongillo EA, et al
    Food insecurity is associated with inflammation among women living with HIV.
    J Infect Dis. 2018 Aug 27. pii: 5080937. doi: 10.1093.
    PubMed     Text format     Abstract available


  14. LETIZIA A, Eller MA, Polyak C, Eller LA, et al
    Biomarkers of Inflammation Correlate with Clinical Scoring Indices in HIV-Infected Kenyans.
    J Infect Dis. 2018 Aug 27. pii: 5082069. doi: 10.1093.
    PubMed     Text format     Abstract available


  15. RICHTERMAN A, Sainvilien DR, Eberly L, Ivers LC, et al
    Individual and Household Risk Factors for Symptomatic Cholera Infection: A Systematic Review and Meta-analysis.
    J Infect Dis. 2018 Aug 18. pii: 5076163. doi: 10.1093.
    PubMed     Text format     Abstract available


  16. CHOW FC, Makanjuola A, Wu K, Berzins B, et al
    Physical activity is associated with lower odds of cognitive impairment in women but not men living with HIV infection.
    J Infect Dis. 2018 Aug 18. pii: 5075993. doi: 10.1093.
    PubMed     Text format     Abstract available


  17. PUDNEY J, Wangu Z, Panther L, Fugelso D, et al
    Condylomata acuminata (anogenital warts) contain accumulations of HIV-1 target cells that may provide portals for HIV transmission.
    J Infect Dis. 2018 Aug 18. pii: 5076076. doi: 10.1093.
    PubMed     Text format     Abstract available


  18. SINGH U, Levy J, Armstrong W, Bedimo R, et al
    Policy Recommendations for Optimizing the Infectious Diseases Physician-Scientist Workforce.
    J Infect Dis. 2018;218.
    PubMed     Text format     Abstract available


  19. MERIGAN TC
    Role of Physician-Scientists in the Control of Human Immunodeficiency Virus.
    J Infect Dis. 2018;218.
    PubMed     Text format     Abstract available


  20. FITZGERALD FC, Lhomme E, Harris K, Kenny J, et al
    Microbial translocation does not drive immune activation in Ugandan children with HIV.
    J Infect Dis. 2018 Aug 11. pii: 5070381. doi: 10.1093.
    PubMed     Text format     Abstract available


  21. THOENS C, Heinold A, Lindemann M, Horn PA, et al
    A single nucleotide polymorphism upstream of the HLA-C locus is associated with an anti-HCV seronegative state in a high-risk exposed cohort.
    J Infect Dis. 2018 Aug 9. pii: 5068404. doi: 10.1093.
    PubMed     Text format     Abstract available


  22. NAMAZI G, Fajnzylber JM, Aga E, Bosch R, et al
    The Control of HIV after Antiretroviral Medication Pause (CHAMP) study: post-treatment controllers identified from 14 clinical studies.
    J Infect Dis. 2018 Aug 6. pii: 5067282. doi: 10.1093.
    PubMed     Text format     Abstract available


  23. DARCIS G, Berkhout B
    HIV resistance to dolutegravir: are we looking at the wrong place?
    J Infect Dis. 2018 Aug 2. pii: 5063806. doi: 10.1093.
    PubMed     Text format    


    July 2018
  24. DHUMMAKUPT A, Siems LV, Singh D, Chen YH, et al
    The Latent HIV Reservoir Resides Primarily in CD32- CD4+ T Cells in Perinatally, HIV-Infected Adolescents with Long-Term Virologic Suppression.
    J Infect Dis. 2018 Jul 21. pii: 5057007. doi: 10.1093.
    PubMed     Text format     Abstract available


  25. LIU Y, Sigel K, Gaisa MM
    HPV Genotypes Predict Progression of Anal Low-grade Squamous Intraepithelial Lesions.
    J Infect Dis. 2018 Jul 21. pii: 5057008. doi: 10.1093.
    PubMed     Text format     Abstract available


  26. SIEDNER MJ, Triant V
    Undetectable = Untransmittable and Your Health: The personal benefits of early and continuous therapy for HIV infection.
    J Infect Dis. 2018 Jul 19. pii: 5055762. doi: 10.1093.
    PubMed     Text format    


  27. ZHANG WW, Cheung PK, Oliviera N, Robbins MA, et al
    Accumulation of multiple mutations in vivo confers cross-resistance to new and existing integrase inhibitors.
    J Infect Dis. 2018 Jul 16. pii: 5054084. doi: 10.1093.
    PubMed     Text format     Abstract available


  28. DENNIS AM, Zhou S, Sellers CJ, Learner E, et al
    Using Primer-ID Deep Sequencing to Detect Recent HIV-1 Infection.
    J Infect Dis. 2018 Jul 16. pii: 5054087. doi: 10.1093.
    PubMed     Text format     Abstract available


  29. YOON HA, Nakouzi A, Chang CC, Kuniholm MH, et al
    Association between plasma antibody responses and risk for Cryptococcus-associated immune reconstitution inflammatory syndrome.
    J Infect Dis. 2018 Jul 16. pii: 5054280. doi: 10.1093.
    PubMed     Text format     Abstract available


  30. WERTHEIM JO, Murrell B, Mehta SR, Forgione LA, et al
    Growth of HIV-1 Molecular Transmission Clusters in New York City.
    J Infect Dis. 2018 Jul 14. pii: 5053881. doi: 10.1093.
    PubMed     Text format     Abstract available


  31. LOPEZ-CORTES LF, Trujillo-Rodriguez M, Baez-Palomo A, Benmarzouk-Hidalgo OJ, et al
    Eradication of Hepatitis C Virus (HCV) Reduces Immune Activation, Microbial Translocation, and the HIV DNA Level in HIV/HCV-Coinfected Patients.
    J Infect Dis. 2018 Jul 6. pii: 5050122. doi: 10.1093.
    PubMed     Text format     Abstract available


  32. JOSE S, Hamzah L, Jones R, Williams D, et al
    Chronic Kidney Disease Risk in African and Caribbean Populations with HIV.
    J Infect Dis. 2018 Jul 6. pii: 5049787. doi: 10.1093.
    PubMed     Text format     Abstract available


  33. NING T, Nie J, Huang W, Li C, et al
    Antigenic Drift of H7N9 Viral Hemagglutinin.
    J Infect Dis. 2018 Jul 5. pii: 5049177. doi: 10.1093.
    PubMed     Text format     Abstract available


  34. STELLA-ASCARIZ N, Montejano R, Rodriguez-Centeno J, Alejos B, et al
    Blood Telomere Length Changes after Ritonavir-boosted Darunavir Combined with Raltegravir or Tenofovir-Emtricitabine in Antiretroviral-Naive Adults Infected with HIV-1.
    J Infect Dis. 2018 Jul 3. pii: 5048609. doi: 10.1093.
    PubMed     Text format     Abstract available


  35. GEBREMICAEL G, Kassa D, Quinten E, Alemayehu Y, et al
    Host gene expression kinetics during treatment of tuberculosis in HIV-coinfected individuals is independent of HAART therapy.
    J Infect Dis. 2018 Jul 2. pii: 5047436. doi: 10.1093.
    PubMed     Text format     Abstract available


  36. FULCHER JA, Hussain SK, Cook R, Li F, et al
    Effects of Substance Use and Sex Practices on the Intestinal Microbiome During HIV-1 Infection.
    J Infect Dis. 2018 Jul 2. pii: 5047923. doi: 10.1093.
    PubMed     Text format     Abstract available


    June 2018
  37. RAMJEE G, Dassaye R, Reddy T, Wand H, et al
    Targeted pregnancy and HIV prevention risk-reduction counselling for young women: lessons learned from biomedical prevention trials.
    J Infect Dis. 2018 Jun 26. pii: 5045583. doi: 10.1093.
    PubMed     Text format     Abstract available


  38. SHIPLEY MM, Renner DW, Ott M, Bloom DC, et al
    Genome-Wide Surveillance of Genital Herpes Simplex Virus Type 1 From Multiple Anatomic Sites Over Time.
    J Infect Dis. 2018 Jun 18. pii: 5039658. doi: 10.1093.
    PubMed     Text format     Abstract available


  39. MESHER D, Panwar K, Thomas SL, Edmundson C, et al
    The Impact of the National HPV Vaccination Program in England Using the Bivalent HPV Vaccine: Surveillance of Type-Specific HPV in Young Females, 2010-2016.
    J Infect Dis. 2018 Jun 18. pii: 5025126. doi: 10.1093.
    PubMed     Text format     Abstract available


  40. COTE HCF, Hsieh AYY
    Leukocyte telomere length in HIV infection: A marker of persistent immune aging or transient immune reconstitution?
    J Infect Dis. 2018 Jun 15. pii: 5038297. doi: 10.1093.
    PubMed     Text format    


  41. MONTEJANO R, Stella-Ascariz N, Monge S, Bernardino JI, et al
    Impact of Nucleos(t)ide Reverse Transcriptase Inhibitors on Blood Telomere Length Changes in a Prospective Cohort of Aviremic HIV-1 infected Adults.
    J Infect Dis. 2018 Jun 15. pii: 5038298. doi: 10.1093.
    PubMed     Text format     Abstract available


  42. SHAN Z, Clish CB, Hua S, Scott JM, et al
    Gut Microbial-related Choline Metabolite Trimethylamine-N-oxide is Associated with Progression of Carotid Artery Atherosclerosis in HIV Infection.
    J Infect Dis. 2018 Jun 15. pii: 5038303. doi: 10.1093.
    PubMed     Text format     Abstract available


  43. RAO M, Onkar S, Peachman KK, White Y, et al
    Liposome-Encapsulated HIV-1 gp120 Induces Potent V1V2-Specific Antibodies in Humans.
    J Infect Dis. 2018 Jun 9. pii: 5035293. doi: 10.1093.
    PubMed     Text format     Abstract available


  44. ALI A, Ng HL, Blankson JN, Burton DR, et al
    Highly Attenuated Infection with a Vpr-Deleted Molecular Clone of HIV-1.
    J Infect Dis. 2018 Jun 7. pii: 5033983. doi: 10.1093.
    PubMed     Text format     Abstract available


  45. LIDOFSKY A, Holmes JA, Feeney ER, Kruger AJ, et al
    Macrophage Activation Marker Soluble CD163 is a Dynamic Marker of Liver Fibrogenesis in HIV/HCV Coinfection.
    J Infect Dis. 2018 Jun 4. pii: 5032604. doi: 10.1093.
    PubMed     Text format     Abstract available


  46. D'ANTONI ML, Byron MM, Chan P, Sailasuta N, et al
    Normalization of Soluble CD163 after Institution of Antiretroviral Therapy During Acute HIV Infection Tracks with Fewer Neurological Abnormalities.
    J Infect Dis. 2018 Jun 2. pii: 5032504. doi: 10.1093.
    PubMed     Text format     Abstract available


    May 2018
  47. JOHNSON EL, Boggavarapu S, Johnson ES, Lal A, et al
    HCMV enhances placental susceptibility and replication of HIV-1 which may facilitate in utero HIV-1 transmission.
    J Infect Dis. 2018 May 31. pii: 5026120. doi: 10.1093.
    PubMed     Text format     Abstract available


  48. KELLY H, Faust H, Chikandiwa A, Ngou J, et al
    Human Papillomavirus Serology Among Women Living With HIV: Type-Specific Seroprevalence, Seroconversion, and Risk of Cervical Reinfection.
    J Infect Dis. 2018 May 30. pii: 5025554. doi: 10.1093.
    PubMed     Text format     Abstract available


  49. PERCIANI CT, Sekhon M, Hundal S, Farah B, et al
    Live-attenuated Zoster Vaccine Boosts VZV-specific Humoral Responses Systemically and at the Cervico-vaginal Mucosa of Kenyan VZV-seropositive Women.
    J Infect Dis. 2018 May 25. pii: 5003463. doi: 10.1093.
    PubMed     Text format     Abstract available


  50. ANDERSEN MN, Honge BL, Jespersen S, Medina C, et al
    Soluble Macrophage Mannose Receptor (sCD206/sMR) as a Biomarker in HIV-infection.
    J Infect Dis. 2018 May 25. pii: 5003428. doi: 10.1093.
    PubMed     Text format     Abstract available


  51. VON MOLLENDORF C, Hellferscee O, Valley-Omar Z, Treurnicht FK, et al
    Influenza viral shedding in a prospective cohort of HIV-infected and -uninfected children and adults in 2 provinces of South Africa, 2012-2014.
    J Infect Dis. 2018 May 24. pii: 5002738. doi: 10.1093.
    PubMed     Text format     Abstract available



  52. Erratum to Evaluating the Impact of Functional Genetic Variation on HIV-1 Control.
    J Infect Dis. 2018 May 24. pii: 5003198. doi: 10.1093.
    PubMed     Text format    


  53. DOBARD CW, Makarova N, West-Deadwyler R, Taylor A, et al
    Efficacy of Vaginally Administered Gel Containing Emtricitabine and Tenofovir Against Repeated Rectal SHIV Exposures in Macaques.
    J Infect Dis. 2018 May 21. pii: 4999973. doi: 10.1093.
    PubMed     Text format     Abstract available


  54. LANGKILDE A, Tavenier J, Danielsen AV, Eugen-Olsen J, et al
    Histological and Molecular Adipose Tissue Changes are related to Metabolic Syndrome rather than Lipodystrophy in HIV-infected Patients-A Cross-Sectional Study.
    J Infect Dis. 2018 May 17. pii: 4997383. doi: 10.1093.
    PubMed     Text format     Abstract available


  55. TWISK DE, van der Sande MAB, van Eeden A, Heideman DAM, et al
    Detection of Incident Anal High-Risk Hpv-Dna in Msm: Incidence or Reactivation?
    J Infect Dis. 2018 May 16. pii: 4996623. doi: 10.1093.
    PubMed     Text format     Abstract available


  56. REICHLER MR, Khan A, Sterling TR, Zhao H, et al
    Risk and Timing of Tuberculosis Among Close Contacts of Persons with Infectious Tuberculosis.
    J Infect Dis. 2018 May 15. pii: 4996045. doi: 10.1093.
    PubMed     Text format     Abstract available


  57. KOAY WLA, Lindsey JC, Uprety P, Bwakura-Dangarembizi M, et al
    Intestinal Integrity Biomarkers in Early Antiretroviral-Treated Perinatally HIV-1-Infected Infants.
    J Infect Dis. 2018 May 12. pii: 4995578. doi: 10.1093.
    PubMed     Text format     Abstract available


  58. NALWOGA A, Cose S, Nash S, Miley W, et al
    Relationship between Anaemia, Malaria Co-infection and Kaposi Sarcoma-associated Herpesvirus (KSHV) Seropositivity in a Population-based Study in Rural Uganda.
    J Infect Dis. 2018 May 8. pii: 4993751. doi: 10.1093.
    PubMed     Text format     Abstract available


  59. CHAN P, Patel P, Hellmuth J, Colby DJ, et al
    Distribution of HIV RNA in CSF and Blood is linked to CD4/CD8 Ratio During Acute HIV.
    J Infect Dis. 2018 May 7. pii: 4993332. doi: 10.1093.
    PubMed     Text format     Abstract available


  60. FARMAKI PF, Chini MC, Mangafas NM, Tzanoudaki MT, et al
    Immunogenicity and Immunological Memory Induced by the 13-Valent Pneumococcal Conjugate Followed by the 23-Valent Polysaccharide Vaccine in HIV-Infected Adults.
    J Infect Dis. 2018 May 2. pii: 4990938. doi: 10.1093.
    PubMed     Text format     Abstract available


    April 2018
  61. SIEDNER MJ, Zanni M, Tracy RP, Kwon DS, et al
    Increased Systemic Inflammation and Gut Permeability Among Women with Treated HIV Infection in Rural Uganda.
    J Infect Dis. 2018 Apr 28. pii: 4989852. doi: 10.1093.
    PubMed     Text format     Abstract available


  62. KOSTAKI EG, Nikolopoulos GK, Pavlitina E, Williams L, et al
    Molecular analysis of HIV-1 infected individuals in a network-based intervention (TRIP): Phylogenetics identify HIV-1 infected individuals with social links.
    J Infect Dis. 2018 Apr 24. pii: 4984584. doi: 10.1093.
    PubMed     Text format     Abstract available


  63. COLBY DJ, Posuwan N, Kroon E, Phanuphak N, et al
    Reply to Chen et al.
    J Infect Dis. 2018 Apr 23. pii: 4982816. doi: 10.1093.
    PubMed     Text format    


  64. HOSHINO A, Takashima T, Yoshida K, Morimoto A, et al
    Dysregulation of Epstein-Barr virus infection in hypomorphic ZAP70 mutation.
    J Infect Dis. 2018 Apr 19. pii: 4976509. doi: 10.1093.
    PubMed     Text format     Abstract available


  65. LIN KY, Hsieh SM, Sheng WH, Lo YC, et al
    Comparable serologic responses to 2 different combinations of inactivated HAV vaccines in HIV-positive patients during the acute hepatitis A outbreak in Taiwan.
    J Infect Dis. 2018 Apr 16. pii: 4972613. doi: 10.1093.
    PubMed     Text format     Abstract available


  66. BADEN LR, Walsh SR, Seaman MS, Cohen YZ, et al
    First-in-Human Randomized Controlled Trial of Mosaic HIV-1 Immunogens Delivered via a Modified Vaccinia Ankara Vector.
    J Infect Dis. 2018 Apr 13. pii: 4969772. doi: 10.1093.
    PubMed     Text format     Abstract available


  67. REICHLER MR, Bangura J, Bruden D, Keimbe C, et al
    Household Transmission of Ebola Virus: risks and preventive factors, Freetown, Sierra Leone, 2015.
    J Infect Dis. 2018 Apr 6. pii: 4962469. doi: 10.1093.
    PubMed     Text format     Abstract available


  68. BRADLEY J, Floyd S, Piwowar-Manning E, Laeyendecker O, et al
    Sexually Transmitted Bedfellows: Exquisite Association between HIV and HSV2 in 21 Communities in Southern Africa in the HPTN 071 (PopART) Study.
    J Infect Dis. 2018 Apr 6. pii: 4962568. doi: 10.1093.
    PubMed     Text format     Abstract available


    March 2018
  69. PRINCIOTTO AM, Vrbanac VD, Melillo B, Park J, et al
    A Small-Molecule CD4-mimetic Compound Protects BLT Humanized Mice from Human Immunodeficiency Virus Infection.
    J Infect Dis. 2018 Mar 29. pii: 4956165. doi: 10.1093.
    PubMed     Text format     Abstract available


  70. PHAM HT, Labrie L, Wijting IEA, Hassounah S, et al
    The S230R Integrase Substitution Associated with Viral Rebound during DTG Monotherapy Confers Low Levels INSTI Drug Resistance.
    J Infect Dis. 2018 Mar 29. pii: 4956223. doi: 10.1093.
    PubMed     Text format     Abstract available


  71. WIJTING IEA, Lungu C, Rijnders BJA, van der Ende ME, et al
    HIV-1 resistance dynamics in patients failing dolutegravir maintenance monotherapy.
    J Infect Dis. 2018 Mar 29. pii: 4956224. doi: 10.1093.
    PubMed     Text format     Abstract available


  72. SCHUSTER C, Mayer FJ, Wohlfahrt C, Marculescu R, et al
    Acute HIV Infection Results in Subclinical Inflammatory Cardiomyopathy.
    J Infect Dis. 2018 Mar 28. pii: 4955987. doi: 10.1093.
    PubMed     Text format     Abstract available


  73. SSEMWANGA D, Doria-Rose NA, Redd AD, Shiakolas AR, et al
    Characterization of the Neutralizing Antibody Response in a Case of Genetically Linked HIV Superinfection.
    J Infect Dis. 2018 Mar 22. pii: 4932787. doi: 10.1093.
    PubMed     Text format     Abstract available


  74. POON AFY, Dearlove BL
    Quantifying the aftermath: Recent Outbreaks among People who in- ject Drugs and the Utility of Phylodynamics.
    J Infect Dis. 2018 Mar 13. pii: 4931170. doi: 10.1093.
    PubMed     Text format    


  75. MURRAY LW, Satti I, Meyerowitz J, Jones M, et al
    Human Immunodeficiency Virus Infection Impairs Th1 and Th17 Mycobacterium tuberculosis-Specific T-Cell Responses.
    J Infect Dis. 2018 Mar 13. pii: 4932783. doi: 10.1093.
    PubMed     Text format     Abstract available


  76. RAGONNET-CRONIN M, Jackson C, Bradley-Stewart A, Aitken C, et al
    Recent and Rapid Transmission of HIV among People who Inject Drugs in Scotland Revealed through Phylogenetic Analysis.
    J Infect Dis. 2018 Mar 13. pii: 4931169. doi: 10.1093.
    PubMed     Text format     Abstract available


  77. STROUVELLE VP, Braun DL, Vongrad V, Scherrer AU, et al
    No Effect of Pegylated Interferon-alpha on Total Hiv-1 DNA Load in HIV-1/HCV Coinfected Patients.
    J Infect Dis. 2018 Mar 8. pii: 4924783. doi: 10.1093.
    PubMed     Text format     Abstract available


  78. THOMSON KA, Hughes J, Baeten JM, John-Stewart G, et al
    Increased Risk of Female HIV-1 Acquisition Throughout Pregnancy and Postpartum: A Prospective Per-coital Act Analysis Among Women with HIV-1 Infected Partners.
    J Infect Dis. 2018 Mar 5. pii: 4915924. doi: 10.1093.
    PubMed     Text format     Abstract available


  79. STEFIC K, Novelli S, Mahjoub N, Seng R, et al
    Non-reactive HIV-1 Rapid Tests after Sustained Viral Suppression Following Antiretroviral Therapy Initiation During Primary Infection.
    J Infect Dis. 2018 Mar 2. pii: 4917573. doi: 10.1093.
    PubMed     Text format     Abstract available


    February 2018
  80. MOFENSON LM
    Risk of HIV Acquisition during Pregnancy and Postpartum: A Call for Action.
    J Infect Dis. 2018 Feb 28. pii: 4913312. doi: 10.1093.
    PubMed     Text format    


  81. VOLZ EM, Le Vu S, Ratmann O, Tostevin A, et al
    Molecular Epidemiology of HIV-1 Subtype B Reveals Heterogeneous Transmission Risk: Implications for Intervention and Control.
    J Infect Dis. 2018 Feb 26. pii: 4915980. doi: 10.1093.
    PubMed     Text format     Abstract available


  82. BAETEN JM
    Amplifying the Population Health Benefits of PrEP for HIV Prevention.
    J Infect Dis. 2018 Feb 26. pii: 4915988. doi: 10.1093.
    PubMed     Text format    


  83. MARGOLICK JB, Bream JH, Nilles TL, Li H, et al
    Relationship Between T-Cell Responses to CMV, Markers of Inflammation, and Frailty in HIV-uninfected and HIV-infected Men in the Multicenter AIDS Cohort Study.
    J Infect Dis. 2018 Feb 26. pii: 4909741. doi: 10.1093.
    PubMed     Text format     Abstract available


  84. GANDHI M, Gandhi RT, Stefanescu A, Bosch RJ, et al
    Cumulative Antiretroviral Exposure Measured in Hair Is Not Associated With Measures of HIV Persistence or Inflammation Among Individuals on Suppressive ART.
    J Infect Dis. 2018 Feb 26. pii: 4848924. doi: 10.1093.
    PubMed     Text format     Abstract available


  85. RODRIGUEZ KM, Khalili J, Trevillian J, Currier J, et al
    What is the best model for HIV Primary Care? Assessing the influence of provider type on outcomes of chronic co-morbidities in HIV.
    J Infect Dis. 2018 Feb 22. pii: 4898101. doi: 10.1093.
    PubMed     Text format    


  86. KOJIC EM, Conley L, Bush T, Cu-Uvin S, et al
    Prevalence and Incidence of Anal and Cervical High-Risk Human Papillomavirus (HPV) Types covered by Current HPV Vaccines among HIV-Infected Women in the Study to Understand the Natural History of HIV/AIDS in the Era of Effective Therapy (The SUN Study
    J Infect Dis. 2018 Feb 14. pii: 4857222. doi: 10.1093.
    PubMed     Text format     Abstract available


  87. KURODA MJ, Sugimoto C, Cai Y, Merino KM, et al
    High Turnover of Tissue Macrophages Contributes to Tuberculosis Reactivation in Simian Immunodeficiency Virus-Infected Rhesus Macaques.
    J Infect Dis. 2018 Feb 8. pii: 4843840. doi: 10.1093.
    PubMed     Text format     Abstract available


  88. KHAN N, Divangahi M
    Mycobacterium tuberculosis and HIV Coinfection Brings Fire and Fury to Macrophages.
    J Infect Dis. 2018 Feb 8. pii: 4843841. doi: 10.1093.
    PubMed     Text format    


  89. UTAY NS, Kitch DW, Yeh E, Fichtenbaum CJ, et al
    Telmisartan Does Not Improve Lymph Node or Adipose Tissue Fibrosis More Than Continued ART Alone.
    J Infect Dis. 2018 Feb 1. pii: 4833221. doi: 10.1093.
    PubMed     Text format     Abstract available


  90. SHANG L, Smith AJ, Duan L, Perkey KE, et al
    Vaccine-associated maintenance of epithelial integrity correlated with protection against virus entry.
    J Infect Dis. 2018 Feb 1. pii: 4833184. doi: 10.1093.
    PubMed     Text format     Abstract available


  91. BURBELO PD, Price RW, Hagberg L, Hatano H, et al
    Anti-Human Immunodeficiency Virus Antibodies in the Cerebrospinal Fluid: Evidence of Early Treatment Impact on Central Nervous System Reservoir?
    J Infect Dis. 2018 Feb 1. pii: 4834093. doi: 10.1093.
    PubMed     Text format     Abstract available


  92. CLIFFORD DB
    Could We Harness Human Immunodeficiency Virus Antibodies to Monitor the Brain?
    J Infect Dis. 2018 Feb 1. pii: 4832662. doi: 10.1093.
    PubMed     Text format    


    January 2018
  93. COMBES JD, Heard I, Poizot-Martin I, Canestri A, et al
    Prevalence and risk factors for anal human papillomavirus infection in HIV-positive men having sex with men.
    J Infect Dis. 2018 Jan 31. pii: 4830905. doi: 10.1093.
    PubMed     Text format     Abstract available


  94. ALLERS K, Kunkel D, Hofmann J, Stahl-Hennig C, et al
    Cell-associated SIV Accelerates Initial Virus Spread and CD4+ T cell Depletion in the Intestinal Mucosa.
    J Infect Dis. 2018 Jan 30. pii: 4829896. doi: 10.1093.
    PubMed     Text format     Abstract available


  95. WILSON P, Parr JB, Jhaveri R, Meshnick SR, et al
    Call to action: Prevention of mother-to-child transmission of hepatitis B in Africa.
    J Infect Dis. 2018 Jan 17. pii: 4812591. doi: 10.1093.
    PubMed     Text format     Abstract available


  96. COLLADO-DIAZ V, Andujar I, Sanchez-Lopez A, Orden S, et al
    Abacavir induces arterial thrombosis in a murine model.
    J Infect Dis. 2018 Jan 16. pii: 4810700. doi: 10.1093.
    PubMed     Text format     Abstract available


  97. PANDEY JP
    HIV-1 Control and Immunoglobulin Genes.
    J Infect Dis. 2018 Jan 15. pii: 4808592. doi: 10.1093.
    PubMed     Text format    


  98. FONG Y, Shen X, Ashley VC, Deal A, et al
    Vaccine-induced antibody responses modify the association between T-cell immune responses and HIV-1 infection risk in HVTN 505.
    J Infect Dis. 2018 Jan 8. pii: 4792964. doi: 10.1093.
    PubMed     Text format     Abstract available


  99. REID M, Ma Y, Scherzer R, Price JC, et al
    Contribution of liver fibrosis and microbial translocation to immune activation in HIV and HCV.
    J Infect Dis. 2018 Jan 3. pii: 4786614. doi: 10.1093.
    PubMed     Text format     Abstract available


    December 2017
  100. ANGELIDOU K, Hunt PW, Landay AL, Wilson CC, et al
    Changes in inflammation but not in T cell activation precede non-AIDS-defining events in a case-control study of patients on long-term antiretroviral therapy.
    J Infect Dis. 2017 Dec 22. pii: 4772233. doi: 10.1093.
    PubMed     Text format     Abstract available


  101. KOOIJ KW, Vogt L, Reiss P
    Reply to Moso et al.
    J Infect Dis. 2017 Dec 22. pii: 4772651. doi: 10.1093.
    PubMed     Text format    


  102. MOSO MA, Woolnough E, Langham F, Hoy JF, et al
    Increasing prevalence and risk of chronic kidney disease in HIV-positive individuals: changing demographics over a six-year period.
    J Infect Dis. 2017 Dec 22. pii: 4772637. doi: 10.1093.
    PubMed     Text format    


  103. TANSEY C, Zhao C, Hopkins A, Ritter JM, et al
    A Non-human Primate Model for Rectally Transmitted Syphilis.
    J Infect Dis. 2017 Dec 22. pii: 4772175. doi: 10.1093.
    PubMed     Text format     Abstract available


  104. GIBBS A, Buggert M, Edfeldt G, Ranefall P, et al
    HIV-infected women have high numbers of CD103-CD8+ T cells residing close to the basal membrane of the ectocervical epithelium.
    J Infect Dis. 2017 Dec 20. pii: 4767924. doi: 10.1093.
    PubMed     Text format     Abstract available


  105. SHIELS MS, Kirk GD, Drummond MB, Dhillon D, et al
    HIV Infection and Circulating Levels of Prosurfactant Protein B and Surfactant Protein D.
    J Infect Dis. 2017 Dec 19. pii: 4762465. doi: 10.1093.
    PubMed     Text format     Abstract available


  106. WALLENDER E, Vucicevic K, Jagannathan P, Huang L, et al
    Predicting optimal dihydroartemisinin-piperaquine regimens to prevent malaria during pregnancy for HIV-infected women receiving efavirenz.
    J Infect Dis. 2017 Dec 19. pii: 4762345. doi: 10.1093.
    PubMed     Text format     Abstract available


  107. GALLANT J, Hsue PY, Shreay S, Meyer N, et al
    Comorbidities Among US Patients With Prevalent HIV Infection-A Trend Analysis.
    J Infect Dis. 2017;216:1525-1533.
    PubMed     Text format     Abstract available


  108. VAN DER VALK M, Reiss P
    Noncommunicable Diseases in People Living With HIV: Time for Integrated Care.
    J Infect Dis. 2017;216:1481-1483.
    PubMed     Text format    


  109. BOPPANA SB, Britt WJ, Fowler K, Hutto SC, et al
    Pathogenesis of Non-Zika Congenital Viral Infections.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


  110. GREGORY CJ, Oduyebo T, Brault AC, Brooks JT, et al
    Modes of Transmission of Zika Virus.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


  111. SIEDNER MJ, Hunt PW
    All About the Albumin? Prognostic Capacity of Serum Albumin in Patients With Treated HIV Infection.
    J Infect Dis. 2017 Dec 13. pii: 4736315. doi: 10.1093.
    PubMed     Text format    


  112. RONIT A, Sharma S, Baker JV, Mngqibisa R, et al
    Serum Albumin as a Prognostic Marker for Serious Non-AIDS Endpoints in the Strategic Timing of Antiretroviral Treatment (START) Study.
    J Infect Dis. 2017 Dec 13. pii: 4736314. doi: 10.1093.
    PubMed     Text format     Abstract available


  113. KING CC, Ellington SR, Davis NL, Coombs RW, et al
    Prevalence, Magnitude, and Correlates of HIV-1 Genital Shedding in Women on Antiretroviral Therapy.
    J Infect Dis. 2017 Dec 12. pii: 4733301. doi: 10.1093.
    PubMed     Text format     Abstract available


  114. HAYASHI K, Dong H, Kerr T, Dobrer S, et al
    Declining Mortality Rates in HIV-Infected People Who Inject Drugs During a Seek-and-Treat Initiative in Vancouver, Canada, 1996-2014: A Prospective Cohort Study.
    J Infect Dis. 2017 Dec 12. pii: 4731720. doi: 10.1093.
    PubMed     Text format     Abstract available


  115. SIVRO A, McKinnon LR
    Mucosal HIV Shedding During ART.
    J Infect Dis. 2017 Dec 12. pii: 4733302. doi: 10.1093.
    PubMed     Text format    


  116. RANGANATH N, Sandstrom TS, Burke Schinkel SC, Cote SC, et al
    The oncolytic virus, MG1, targets and eliminates latently HIV-1-infected cells: implications for an HIV cure.
    J Infect Dis. 2017 Dec 8. pii: 4706282. doi: 10.1093.
    PubMed     Text format     Abstract available


  117. AJAYKUMAR A, Soudeyns H, Kakkar F, Brophy J, et al
    Leukocyte telomere length at birth and during the early life of HIV-exposed uninfected children following in utero exposure to antiretrovirals.
    J Infect Dis. 2017 Dec 8. pii: 4706016. doi: 10.1093.
    PubMed     Text format     Abstract available


  118. NYITRAY AG, Fujimoto K, Zhao J, Giuliano AR, et al
    Prevalence of and risk factors for anal HPV among a sample of predominantly black men who have sex with men in Houston, Texas.
    J Infect Dis. 2017 Dec 5. pii: 4690591. doi: 10.1093.
    PubMed     Text format     Abstract available


  119. PATEL P, Bush T, Kojic EM, Conley L, et al
    Prevalence, incidence, and clearance of anal high-risk human papillomavirus (HPV) infection among HIV-infected men in the SUN Study.
    J Infect Dis. 2017 Dec 4. pii: 4689803. doi: 10.1093.
    PubMed     Text format     Abstract available


  120. STELLA-ASCARIZ N, Arribas JR, Paredes R, Li JZ, et al
    The Role of HIV-1 Drug-Resistant Minority Variants in Treatment Failure.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


  121. WALLIS CL, Godfrey C, Fitzgibbon JE, Mellors JW, et al
    Key Factors Influencing the Emergence of Human Immunodeficiency Virus Drug Resistance in Low- and Middle-Income Countries.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


  122. RAIZES E, Hader S, Birx D
    Expansion of Viral Load Testing and the Potential Impact on HIV Drug Resistance.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


    November 2017
  123. MAKVANDI-NEJAD S, Laurenson-Schafer H, Wang L, Wellington D, et al
    Lack of Truncated IFITM3 Transcripts in Cells Homozygous for the rs12252-C Variant That is Associated With Severe Influenza Infection.
    J Infect Dis. 2017 Nov 30. pii: 4676001. doi: 10.1093.
    PubMed     Text format     Abstract available


  124. ANDREI G, Gillemot S, Topalis D, Snoeck R, et al
    The anti-HIV drug tenofovir, a reverse transcriptase inhibitor, also targets the herpes simplex virus (HSV) DNA polymerase.
    J Infect Dis. 2017 Nov 23. pii: 4653578. doi: 10.1093.
    PubMed     Text format     Abstract available


  125. BOON D, Redd AD, Layendecker O, Engle R, et al
    Hepatitis E virus seroprevalence and correlates of anti-HEV IgG antibodies in the Rakai District, Uganda.
    J Infect Dis. 2017 Nov 23. pii: 4653785. doi: 10.1093.
    PubMed     Text format     Abstract available


  126. JUSTICE AC, Erlandson KM, Miotti PG, Landay A, et al
    Can Biomarkers Advance HIV Research and Care in the ART Era?
    J Infect Dis. 2017 Nov 20. doi: 10.1093.
    PubMed     Text format     Abstract available


  127. CHAUDHURY CS, Sheehan J, Chairez C, Akoth E, et al
    No Improvement in Hemoglobin A1c Following Hepatitis C Viral Clearance in Patients With and Without HIV.
    J Infect Dis. 2017 Nov 17. doi: 10.1093.
    PubMed     Text format     Abstract available


  128. BUTI M, Riveiro-Barciela M, Esteban R
    Tenofovir Alafenamide Fumarate: A New Tenofovir Prodrug for the Treatment of Chronic Hepatitis B Infection.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


  129. YEN YF, Lan YC, Huang CT, Jen IA, et al
    Human Immunodeficiency Virus Infection Increases the Risk of Incident Autoimmune Hemolytic Anemia: A Population-Based Cohort Study in Taiwan.
    J Infect Dis. 2017;216:1000-1007.
    PubMed     Text format     Abstract available


  130. HUANG YA, Tao G, Samandari T, Hoover KW, et al
    Laboratory Testing of a Cohort of Commercially Insured Users of HIV Preexposure Prophylaxis in the United States, 2011-2015.
    J Infect Dis. 2017 Nov 14. doi: 10.1093.
    PubMed     Text format     Abstract available


  131. STEBA GS, Koekkoek SM, Vanhommerig JW, Brinkman K, et al
    DC-SIGN Polymorphisms Associated with Risk of Hepatitis C Virus Infection Among Men who Have Sex with Men but not Among Injecting Drug Users.
    J Infect Dis. 2017 Nov 13. doi: 10.1093.
    PubMed     Text format     Abstract available


  132. REID MJA, Goosby E
    Patient-Centered Tuberculosis Programs Are Necessary to End the Epidemic.
    J Infect Dis. 2017;216.
    PubMed     Text format    


  133. NAIDOO P, Theron G, Rangaka MX, Chihota VN, et al
    The South African Tuberculosis Care Cascade: Estimated Losses and Methodological Challenges.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


  134. CHURCHYARD G, Kim P, Shah NS, Rustomjee R, et al
    What We Know About Tuberculosis Transmission: An Overview.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


  135. MATHEMA B, Andrews JR, Cohen T, Borgdorff MW, et al
    Drivers of Tuberculosis Transmission.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


  136. AULD SC, Kasmar AG, Dowdy DW, Mathema B, et al
    Research Roadmap for Tuberculosis Transmission Science: Where Do We Go From Here and How Will We Know When We're There?
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


  137. SHAH NS, Kim P, Kana BD, Rustomjee R, et al
    Getting to Zero New Tuberculosis Infections: Insights From the National Institutes of Health/US Centers for Disease Control and Prevention/Bill & Melinda Gates Foundation Workshop on Research Needs for Halting Tuberculosis Transmission.
    J Infect Dis. 2017;216.
    PubMed     Text format    


  138. NEWTON R, Labo N, Wakeham K, Miley W, et al
    Kaposi's sarcoma associated herpesvirus in a rural Ugandan cohort: 1992-2008.
    J Infect Dis. 2017 Nov 1. doi: 10.1093.
    PubMed     Text format     Abstract available


    October 2017
  139. VAN ZOEST RA, Underwood J, De Francesco D, Sabin CA, et al
    Structural brain abnormalities in successfully treated HIV infection: associations with disease and cerebrospinal fluid biomarkers.
    J Infect Dis. 2017 Oct 24. doi: 10.1093.
    PubMed     Text format     Abstract available


  140. SIBERRY GK, Amzel A, Ramos A, Rivadeneira ED, et al
    Impact of Human Immunodeficiency Virus Drug Resistance on Treatment of Human Immunodeficiency Virus Infection in Children in Low- and Middle-Income Countries.
    J Infect Dis. 2017 Oct 17. doi: 10.1093.
    PubMed     Text format     Abstract available


  141. KIRKEGAARD-KLITBO DM, Langkilde A, Mejer N, Andersen O, et al
    Soluble Urokinase Plasminogen Activator Receptor Is a Predictor of Incident Non-AIDS Comorbidity and All-Cause Mortality in Human Immunodeficiency Virus Type 1 Infection.
    J Infect Dis. 2017;216:819-823.
    PubMed     Text format     Abstract available


  142. LI G, Nunoya JI, Cheng L, Reszka-Blanco N, et al
    Regulatory T Cells Contribute to HIV-1 Reservoir Persistence in CD4 T Cells Through cAMP-Dependent Mechanisms in Humanized Mice In Vivo.
    J Infect Dis. 2017 Oct 14. doi: 10.1093.
    PubMed     Text format     Abstract available


  143. BERTAGNOLIO S, Beanland RL, Jordan MR, Doherty M, et al
    The World Health Organization's Response to Emerging Human Immunodeficiency Virus Drug Resistance and a Call for Global Action.
    J Infect Dis. 2017 Oct 13. doi: 10.1093.
    PubMed     Text format     Abstract available


  144. DUARTE HA, Panpradist N, Beck IA, Lutz B, et al
    Current Status of Point-of-Care Testing for Human Immunodeficiency Virus Drug Resistance.
    J Infect Dis. 2017 Oct 13. doi: 10.1093.
    PubMed     Text format     Abstract available


  145. PINTYE J, Baeten JM, Celum C, Mugo N, et al
    Maternal tenofovir disoproxil fumarate use during pregnancy is not associated with adverse perinatal outcomes among HIV-infected East African women: a prospective study.
    J Infect Dis. 2017 Oct 10. doi: 10.1093.
    PubMed     Text format     Abstract available


  146. SILVERMAN RA, Beck IA, Kiptinness C, Levine M, et al
    Prevalence of Pre-antiretroviral Treatment Drug Resistance by Gender, Age, and Other Factors in HIV-infected Individuals Initiating Therapy in Kenya, 2013-2014.
    J Infect Dis. 2017 Oct 10. doi: 10.1093.
    PubMed     Text format     Abstract available


  147. NGOBENI R, Samie A, Moonah S, Watanabe K, et al
    Entamoeba Species in South Africa: Correlations With the Host Microbiome, Parasite Burdens, and First Description of Entamoeba bangladeshi Outside of Asia.
    J Infect Dis. 2017 Oct 8. pii: 4372272. doi: 10.1093.
    PubMed     Text format     Abstract available


  148. ROH ME, Shiboski S, Natureeba P, Kakuru A, et al
    Protective effect of indoor residual spraying of insecticide on preterm birth among pregnant women with HIV in Uganda: A secondary data analysis.
    J Infect Dis. 2017 Oct 6. doi: 10.1093.
    PubMed     Text format     Abstract available


  149. MINIOR T, Douglas M, Edgil D, Srivastava M, et al
    The Critical Role of Supply Chains in Preventing Human Immunodeficiency Virus Drug Resistance in Low- and Middle-Income Settings.
    J Infect Dis. 2017 Oct 6. doi: 10.1093.
    PubMed     Text format     Abstract available


  150. ZHUKOVA A, Cutino-Moguel T, Gascuel O, Pillay D, et al
    The Role of Phylogenetics as a Tool to Predict the Spread of Resistance.
    J Infect Dis. 2017 Oct 6. doi: 10.1093.
    PubMed     Text format     Abstract available


  151. SINGH D, Dhummakupt A, Siems L, Persaud D, et al
    Alternative Sample Types for HIV-1 Antiretroviral Drug Resistance Testing.
    J Infect Dis. 2017 Oct 6. doi: 10.1093.
    PubMed     Text format     Abstract available


  152. PARASKEVIS D
    Investigation of Human Immunodeficiency Virus Outbreaks Among People Who Inject Drugs: Timely Diagnosis and Molecular Surveillance are Crucial.
    J Infect Dis. 2017 Oct 5. doi: 10.1093.
    PubMed     Text format    


  153. CHUN HM, Obeng-Aduasare YF, Broyles LN, Ellenberger D, et al
    Expansion of Viral Load Testing and the Potential Impact on Human Immunodeficiency Virus Drug Resistance.
    J Infect Dis. 2017 Oct 5. doi: 10.1093.
    PubMed     Text format     Abstract available


  154. BUNJUN R, Riou C, Soares AP, Thawer N, et al
    Effect of HIV on the frequency and number of Mycobacterium tuberculosis-specific CD4+ T cells in blood and the airways in latent tuberculosis infection.
    J Infect Dis. 2017 Oct 5. doi: 10.1093.
    PubMed     Text format     Abstract available


  155. CAMPBELL EM, Jia H, Shankar A, Hanson D, et al
    Detailed Transmission Network Analysis of a Large Opiate-Driven Outbreak of HIV Infection in the United States.
    J Infect Dis. 2017 Oct 5. doi: 10.1093.
    PubMed     Text format     Abstract available


  156. DONAHUE CARLSON R, Sheth AN, Read TD, Frisch MB, et al
    The Female Genital Tract Microbiome Is Associated With Vaginal Antiretroviral Drug Concentrations in Human Immunodeficiency Virus-Infected Women on Antiretroviral Therapy.
    J Infect Dis. 2017 Oct 5. doi: 10.1093.
    PubMed     Text format     Abstract available


    September 2017
  157. BORRE ED, Hyle EP, Paltiel AD, Neilan AM, et al
    The Clinical and Economic Impact of Attaining National HIV/AIDS Strategy Treatment Targets in the United States.
    J Infect Dis. 2017 Sep 28. doi: 10.1093.
    PubMed     Text format     Abstract available


  158. ADIMORA AA
    Implementing National HIV/AIDS Strategy 2015 Treatment Targets Is Cost-effective and Would Save Lives: What Other Evidence Do We Need?
    J Infect Dis. 2017 Sep 28. doi: 10.1093.
    PubMed     Text format    


  159. PRENDERGAST AJ, Chasekwa B, Rukobo S, Govha M, et al
    Intestinal Damage and Inflammatory Biomarkers in Human Immunodeficiency Virus (HIV)-Exposed and HIV-Infected Zimbabwean Infants.
    J Infect Dis. 2017;216:651-661.
    PubMed     Text format     Abstract available


  160. FOLDI J, Kozhaya L, McCarty B, Mwamzuka M, et al
    HIV-Infected Children Have Elevated Levels of PD-1+ Memory CD4 T Cells With Low Proliferative Capacity and High Inflammatory Cytokine Effector Functions.
    J Infect Dis. 2017;216:641-650.
    PubMed     Text format     Abstract available


  161. ROCKWOOD N, Sirgel F, Streicher E, Warren R, et al
    Low Frequency of Acquired Isoniazid and Rifampicin Resistance in Rifampicin-Susceptible Pulmonary Tuberculosis in a Setting of High HIV-1 Infection and Tuberculosis Coprevalence.
    J Infect Dis. 2017;216:632-640.
    PubMed     Text format     Abstract available


  162. KOOIJ KW, Vogt L, Wit FWNM, van der Valk M, et al
    Higher Prevalence and Faster Progression of Chronic Kidney Disease in Human Immunodeficiency Virus-Infected Middle-Aged Individuals Compared With Human Immunodeficiency Virus-Uninfected Controls.
    J Infect Dis. 2017;216:622-631.
    PubMed     Text format     Abstract available


  163. MOORE T, Dembry LM, Saag MS
    Sunday in the Park with Infectious Disease: Workforce Mismatch in a Colorful Universe of Possibilities.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


  164. GALLANT JE
    Human Immunodeficiency Virus Medicine.
    J Infect Dis. 2017;216.
    PubMed     Text format    


  165. PIROFSKI LA
    Life as an Infectious Diseases Physician Scientist: Science is Humanity's Lifeline.
    J Infect Dis. 2017;216.
    PubMed     Text format    


  166. DEL RIO C
    From Trained Infectious Diseases Clinician to Global Health Leader, Reflections on the Last 30 Years.
    J Infect Dis. 2017;216.
    PubMed     Text format    


  167. NOGUERA-JULIAN M, Edgil D, Harrigan PR, Sandstrom P, et al
    Next-Generation Human Immunodeficiency Virus Sequencing for Patient Management and Drug Resistance Surveillance.
    J Infect Dis. 2017 Sep 15. doi: 10.1093.
    PubMed     Text format     Abstract available


  168. GODFREY C, Bobkova M, Boucher C, Ravasi G, et al
    Regional Challenges in the Prevention of Human Immunodeficiency Virus Drug Resistance.
    J Infect Dis. 2017 Sep 14. doi: 10.1093.
    PubMed     Text format     Abstract available


  169. CHIKATA T, Murakoshi H, Koyanagi M, Honda K, et al
    Control of HIV-1 by an HLA-B*52:01-C*12:02 protective haplotype.
    J Infect Dis. 2017 Sep 14. doi: 10.1093.
    PubMed     Text format     Abstract available


  170. MCLAREN PJ, Pulit SL, Gurdasani D, Bartha I, et al
    Evaluating the impact of functional genetic variation on HIV-1 control.
    J Infect Dis. 2017 Sep 9. doi: 10.1093.
    PubMed     Text format     Abstract available


  171. LIU Y, Gaisa MM, Wang X, Swartz TH, et al
    Immune Microenvironments of Anal Cancer Precursors Differ by HIV-serostatus, Affecting Ablation Outcomes.
    J Infect Dis. 2017 Sep 2. doi: 10.1093.
    PubMed     Text format     Abstract available


  172. NING T, Wolfe A, Nie J, Huang W, et al
    Naturally Occurring Single Amino Acid Substitution in the L1 Major Capsid Protein of Human Papillomavirus Type 16: Alteration of Susceptibility to Antibody-Mediated Neutralization.
    J Infect Dis. 2017 Sep 2. doi: 10.1093.
    PubMed     Text format     Abstract available


  173. AKE JA, Schuetz A, Pegu P, Wieczorek L, et al
    Safety and Immunogenicity of PENNVAX(R)-G DNA Prime Administered by Biojector(R) 2000 or CELLECTRA(R) Electroporation Device with Modified Vaccinia Ankara-CMDR Boost.
    J Infect Dis. 2017 Sep 2. doi: 10.1093.
    PubMed     Text format     Abstract available


  174. SMITH B
    Toward Understanding the When and Why of Human Immunodeficiency Virus-Associated Stroke.
    J Infect Dis. 2017;216:509-510.
    PubMed     Text format    


  175. BENJAMIN LA, Allain TJ, Mzinganjira H, Connor MD, et al
    The Role of Human Immunodeficiency Virus-Associated Vasculopathy in the Etiology of Stroke.
    J Infect Dis. 2017;216:545-553.
    PubMed     Text format     Abstract available


  176. MOLLAN KR, Tierney C, Hellwege JN, Eron JJ, et al
    Race/Ethnicity and the Pharmacogenetics of Reported Suicidality With Efavirenz Among Clinical Trials Participants.
    J Infect Dis. 2017;216:554-564.
    PubMed     Text format     Abstract available


    August 2017
  177. WEITZMANN MN, Vikulina T, Roser-Page S, Yamaguchi M, et al
    Homeostatic Expansion of CD4+ T-cells Promotes Cortical and Trabecular Bone Loss while CD8+ T-cells Induce Trabecular Bone Loss Only.
    J Infect Dis. 2017 Aug 25. doi: 10.1093.
    PubMed     Text format     Abstract available


  178. ASMUTH DM, Thompson CG, Chun TW, Ma ZM, et al
    Tissue Pharmacologic and Virologic Determinants of Duodenal and Rectal GALT Immune Reconstitution in HIV-infected Patients Initiating Antiretroviral Therapy.
    J Infect Dis. 2017 Aug 23. doi: 10.1093.
    PubMed     Text format     Abstract available


  179. BOEIJEN LL, Montanari NR, de Groen RA, van Oord GW, et al
    Mucosal-associated invariant T (MAIT) cells are more activated in chronic hepatitis B, but not depleted in blood: reversal by antiviral therapy.
    J Infect Dis. 2017 Aug 23. doi: 10.1093.
    PubMed     Text format     Abstract available


  180. DE POKOMANDY A, Kaufman E, de Castro C, Mayrand MH, et al
    The EVVA Cohort Study: Anal and Cervical Type-Specific Human Papillomavirus Prevalence, Persistence, and Cytologic Findings in Women Living With HIV.
    J Infect Dis. 2017;216:447-456.
    PubMed     Text format     Abstract available


  181. CRABTREE KL, Wojcicki JM, Minhas V, Kankasa C, et al
    Food and Drink Sharing in the Household are Associated with HHV-8 Seroconversion in a Cohort of Zambian Children.
    J Infect Dis. 2017 Aug 14. doi: 10.1093.
    PubMed     Text format     Abstract available


    June 2017
  182. GODFREY C, Thigpen MC, Crawford KW, Jean-Phillippe P, et al
    Global HIV Antiretroviral Drug Resistance: A Perspective and Report of a National Institute of Allergy and Infectious Diseases Consultation.
    J Infect Dis. 2017 Jun 17. doi: 10.1093.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: